US · Healthcare

Elixxer Ltd (ELIXF)

Drug Manufacturers - Specialty & Generic

Elixxer Ltd (ELIXF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ELIXF

P/E ratio

18.00

Elixxer Ltd (ELIXF) — FAQ

What is ELIXF's P/E ratio?

The price-to-earnings (P/E) ratio for Elixxer Ltd (ELIXF) is 18.00 (data as of 2026-03-24).

Does Elixxer Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Elixxer Ltd (ELIXF). Check the MyAverix Finance app for the latest dividend data.

What sector is Elixxer Ltd in?

Elixxer Ltd (ELIXF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ELIXF listed on?

ELIXF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)